000 01535nam a22004577a 4500
008 221018s20222022 xxu||||| |||| 00| 0 eng d
022 _a1876-7591
024 _a10.1016/j.jcmg.2022.06.012 [doi]
024 _aS1936-878X(22)00403-X [pii]
040 _aOvid MEDLINE(R)
099 _a36075624
245 _aAtrial Fibrillation and Cardiac Sarcoidosis: The Aperture Widens Through the Lens of FDG-PET Imaging.
251 _aJacc: Cardiovascular Imaging. 15(9):1632-1634, 2022 09.
252 _aJACC Cardiovasc Imaging. 15(9):1632-1634, 2022 09.
253 _aJACC. Cardiovascular imaging
260 _c2022
260 _fFY2023
260 _p2022 09
265 _sppublish
265 _tMEDLINE
266 _d2022-10-20
546 _aEnglish
650 _a*Atrial Fibrillation
650 _a*Cardiomyopathies
650 _a*Sarcoidosis
650 _aAtrial Fibrillation/dg [Diagnostic Imaging]
650 _aCardiomyopathies/dg [Diagnostic Imaging]
650 _aFluorodeoxyglucose F18
650 _aHumans
650 _aPositron-Emission Tomography/mt [Methods]
650 _aPredictive Value of Tests
650 _aRadiopharmaceuticals
650 _aSarcoidosis/dg [Diagnostic Imaging]
651 _aMedStar Heart & Vascular Institute
657 _aComment
657 _aEditorial
700 _aSheikh, Farooq H
_bMHVI
790 _aGilotra NA, Sheikh FH
856 _uhttps://dx.doi.org/10.1016/j.jcmg.2022.06.012
_zhttps://dx.doi.org/10.1016/j.jcmg.2022.06.012
942 _cART
_dArticle
999 _c343
_d343